荣昌生物三年收入翻番,亟待扭亏

财中社APP
12 Apr

荣昌生物连续亏损,导致资产负债率攀升,资金储备恐难以满足未来经营和资本开支需求。作者/曾智编辑/武岩在不可控因素的影响之下,创新药上市公司荣昌生物(688331/09995)股价也受到影响,4月7日收盘跌6.35%,不过之后四个交易日快速收复失地,并再创近期新高。从2025年1月低点算起,公司股价至今已上涨106.55%,4月11日收盘报46.34元,总市值252亿元。天风证券研报指出,关税对...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10